Comparing the Electronic and Standard Versions of the Montreal Cognitive Assessment in an Outpatient Memory Disorders Clinic: A Validation Study

Manuscript Number: 

17-0896R1

Author(s): 
Jody-Lynn Berg, Jeffrey Cummings, January Durant, Gabriel C. Léger, Justin B. Miller, Ziad Nasreddine

Disclosures

Jody-Lynn Berg

  • Nothing to Disclose

Jeffrey Cummings

  • Consulting Fees:
    Dr. Cummings has provided consultation to Acadia, Accera, Actinogen, ADAMAS, Alkahest, Allergan, Alzheon, Astellas, AstraZeneca, Avanir, Axovant, BiOasis Technologies, Biogen, Boehinger-Ingelheim, Bracket, Dart, Eisai, Genentech, Intracellular Therapies, Kyowa, Lilly, Lundbeck, Medavante, Merck, Neurotrope, Novartis, Nutricia, Orion, Otsuka, Pfizer, QR Pharma, Resverlogix, Servier, Suven, Takeda, Toyoma, and United Neuroscience companies.
    Equity:
    Dr. Cummings owns stock in ADAMAS, Prana, Sonexa, MedAvante, Neurotrax, and Neurokos.
    Lecture Fees:
    Lecture fees from Eisai, Pfizer, Axovant,for Alzheimer's Association International Conference and Clinical Trials for Alzheimer's Disease annual conferences.
    Patents/Royalties
    Dr. Cummings owns the copyright of the Neuropsychiatric Inventory (NPI).
    Grants
    • Agency: 
      Teva Pharmaceuticals
      Dates: 
      2015-2018
    • Agency: 
      Avid Pharmaceuticals
      Dates: 
      2015-2018

January Durant

  • Nothing to Disclose

Gabriel C. Léger

  • Nothing to Disclose

Justin B. Miller

  • Nothing to Disclose

Ziad Nasreddine

  • Patents/Royalties
    Copyright owner of the MoCA Test